Financials data is unavailable for this security.
View more
Year on year Joincare Pharmaceutical Group Industry Co Ltd 's net income fell -3.99% from 1.50bn to 1.44bn despite relatively flat revenues. A contributing factor has been an increase in the percentage of sales devoted to the cost of goods sold from 37.18% to 39.71%.
| Gross margin | 61.38% |
|---|---|
| Net profit margin | 18.07% |
| Operating margin | 21.88% |
| Return on assets | 8.03% |
|---|---|
| Return on equity | 10.19% |
| Return on investment | 16.91% |
More ▼
Cash flow in CNYView more
In 2023, Joincare Pharmaceutical Group Industry Co Ltd increased its cash reserves by 8.20%, or 1.16bn. The company earned 3.93bn from its operations for a Cash Flow Margin of 23.60%. In addition the company used 877.42m on investing activities and also paid 1.93bn in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 7.64 |
|---|---|
| Tangible book value per share | 6.66 |
More ▼
Balance sheet in CNYView more
| Current ratio | 2.12 |
|---|---|
| Quick ratio | 1.89 |
| Total debt/total equity | 0.4614 |
|---|---|
| Total debt/total capital | 0.2222 |
More ▼
Growth rates in CNY
Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -4.51%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 1.37% |
|---|---|
| Div growth rate (5 year) | 2.38% |
| Payout ratio (TTM) | 23.92% |
| EPS growth(5 years) | 15.95 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -3.90 |
More ▼
